loadpatents
name:-0.096622943878174
name:-0.072104930877686
name:-0.0023188591003418
HANAI; Nobuo Patent Filings

HANAI; Nobuo

Patent Applications and Registrations

Patent applications and USPTO patent grants for HANAI; Nobuo.The latest application filed is for "method of producing antibodies with n-glycoside-linked sugar chains lacking fucosylation".

Company Profile
2.68.59
  • HANAI; Nobuo - Machida-shi JP
  • Hanai; Nobuo - Tokyo JP
  • Hanai; Nobuo - Machida JP
  • Hanai; Nobuo - Chiyoda-ku JP
  • Hanai; Nobuo - Kanagawa JP
  • Hanai; Nobuo - Sagamihara JP
  • Hanai; Nobuo - Princeton NJ
  • Hanai; Nobuo - Sagamihara-shi JP
  • Hanai; Nobuo - Sagimihara JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method Of Producing Antibodies With N-glycoside-linked Sugar Chains Lacking Fucosylation
App 20200017593 - HANAI; Nobuo ;   et al.
2020-01-16
Antibody Composition-producing Cell
App 20190360015 - Kanda; Yutaka ;   et al.
2019-11-28
Antibody composition-producing cell
Grant 10,233,475 - Kanda , et al.
2019-03-19
Method of modulating the activity of functional immune molecules
Grant 10,233,247 - Hanai , et al.
2019-03-19
Method Of Modulating The Activity Of Functional Immune Molecules
App 20170240647 - HANAI; Nobuo ;   et al.
2017-08-24
Antibody Composition-producing Cell
App 20160348145 - KANDA; Yutaka ;   et al.
2016-12-01
Antibody composition-producing cell
Grant 9,409,982 - Kanda , et al. August 9, 2
2016-08-09
Antibody Composition-producing Cell
App 20150112046 - KANDA; Yutaka ;   et al.
2015-04-23
Antibody composition-producing cell
Grant 8,895,266 - Kanda , et al. November 25, 2
2014-11-25
Method Of Modulating The Activity Of Functional Immune Molecules
App 20140234300 - HANAI; Nobuo ;   et al.
2014-08-21
Method of modulating the activity of functional immune molecules
Grant 8,679,491 - Hanai , et al. March 25, 2
2014-03-25
Method for producing recombinant antibody and antibody fragment thereof
Grant 8,632,996 - Shitara , et al. January 21, 2
2014-01-21
Antibody Composition-producing Cell
App 20130189736 - KANDA; Yutaka ;   et al.
2013-07-25
Cells with altered fucosylation and producing antibodies therefrom
Grant 8,367,407 - Kanda , et al. February 5, 2
2013-02-05
Antibody composition-producing cell
Grant 8,329,443 - Kanda , et al. December 11, 2
2012-12-11
Gene Recombinant Antibody And Antibody Fragment Thereof
App 20120276090 - SHITARA; Kenya ;   et al.
2012-11-01
Method for treating the Th2-mediated disease
Grant 8,197,814 - Shitara , et al. June 12, 2
2012-06-12
Glycoengineered, recombinant antibody
Grant 8,158,760 - Kanda , et al. April 17, 2
2012-04-17
Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody
Grant 8,110,195 - Kanda , et al. February 7, 2
2012-02-07
Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation
Grant 8,101,185 - Kanda , et al. January 24, 2
2012-01-24
Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase
Grant 8,067,232 - Kanda , et al. November 29, 2
2011-11-29
Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation
Grant 8,039,595 - Kanda , et al. October 18, 2
2011-10-18
Antibody Composition-producing Cell
App 20110250643 - KANDA; Yutaka ;   et al.
2011-10-13
Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation
App 20110059115 - KANDA; YUTAKA ;   et al.
2011-03-10
Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation
App 20110052610 - Kanda; Yutaka ;   et al.
2011-03-03
Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation
App 20110027271 - KANDA; Yutaka ;   et al.
2011-02-03
Antibody composition-producing cell in which enzyme expression is inhibited by RNAi
Grant 7,846,725 - Kanda , et al. December 7, 2
2010-12-07
Method for Treating the TH2-Mediated Disease
App 20100221178 - SHITARA; Kenya ;   et al.
2010-09-02
Method Of Modulating The Activity Of Functional Immune Molecules
App 20100196371 - HANAI; NOBUO ;   et al.
2010-08-05
Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor
Grant 7,763,246 - Hanai , et al. July 27, 2
2010-07-27
Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation
Grant 7,741,442 - Kanda , et al. June 22, 2
2010-06-22
Antibody composition-producing cell
Grant 7,737,325 - Kanda , et al. June 15, 2
2010-06-15
Antibody Composition-Producing Cell
App 20100143388 - KANDA; YUTAKA ;   et al.
2010-06-10
Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein
Grant 7,718,175 - Hanai , et al. May 18, 2
2010-05-18
Method of modulating the activity of functional immune molecules
Grant 7,708,997 - Hanai , et al. May 4, 2
2010-05-04
.alpha.-1,3-fucosyltransferase
Grant 7,709,234 - Sasaki , et al. May 4, 2
2010-05-04
Methods for producing antibody compositions with increased ADCC
Grant 7,708,992 - Hanai , et al. May 4, 2
2010-05-04
Method of modulating the activity of functional immune molecules to Her-2
Grant 7,687,061 - Hanai , et al. March 30, 2
2010-03-30
Method of modulating the activity of functional immune molecules to CXCR4 protein
Grant 7,682,611 - Hanai , et al. March 23, 2
2010-03-23
Method of modulating the activity of functional immune molecules
Grant 7,682,610 - Hanai , et al. March 23, 2
2010-03-23
Method for treating Th2-mediated disease
Grant 7,666,418 - Shitara , et al. February 23, 2
2010-02-23
Method of modulating the activity of functional immune molecules to GM2
Grant 7,655,228 - Hanai , et al. February 2, 2
2010-02-02
Method of modulating the activity of functional immune molecules to CD52
Grant 7,651,688 - Hanai , et al. January 26, 2
2010-01-26
Anti-human VEGF receptor Flt-1 monoclonal antibody
Grant 7,615,214 - Shitara , et al. November 10, 2
2009-11-10
Anti-human VEGF receptor Flt-1 monoclonal antibody
Grant 7,615,215 - Shitara , et al. November 10, 2
2009-11-10
Antibody Composition-Producing Cell
App 20090228994 - KANDA; Yutaka ;   et al.
2009-09-10
Glycoengineered, Recombinant Antibody
App 20090191199 - KANDA; Yutaka ;   et al.
2009-07-30
Glycoengineered, Recombinant Antibody
App 20090191592 - KANDA; Yutaka ;   et al.
2009-07-30
Antibody Composition-Producing Cell
App 20080261301 - Kanda; Yutaka ;   et al.
2008-10-23
Antibody against human insulin-like growth factor
Grant 7,438,911 - Shitara , et al. October 21, 2
2008-10-21
Antibody Composition-Producing Cell
App 20080227196 - Kanda; Yutaka ;   et al.
2008-09-18
Antibody composition-producing cell
Grant 7,425,446 - Kanda , et al. September 16, 2
2008-09-16
Anti-human Vegf Receptor Flt-1 Monoclonal Antibody
App 20080187529 - Shitara; Kenya ;   et al.
2008-08-07
Methods using eosinophil-specific apoptosis inducer
Grant 7,404,953 - Hosaka , et al. July 29, 2
2008-07-29
Method of Modulating the Activity of Functional Immune Molecules
App 20080177043 - Hanai; Nobuo ;   et al.
2008-07-24
Mammalian host cell modified by RNAi to inhibit .alpha. 1,6-fucosyltransferase
Grant 7,393,683 - Kanda , et al. July 1, 2
2008-07-01
Method of Modulating the Activity of Functional Immune Molecules
App 20070207151 - Hanai; Nobuo ;   et al.
2007-09-06
Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3
Grant 7,253,263 - Hanai , et al. August 7, 2
2007-08-07
Method of Modulating the Activity of Functional Immune Molecules
App 20070166301 - Hanai; Nobuo ;   et al.
2007-07-19
Method of Modulating the Activity of Functional Immune Molecules
App 20070166302 - Hanai; Nobuo ;   et al.
2007-07-19
Method of Modulating the Activity of Functional Immune Molecules
App 20070166303 - Hanai; Nobuo ;   et al.
2007-07-19
Method of Modulating the Activity of Functional Immune Molecules
App 20070166304 - Hanai; Nobuo ;   et al.
2007-07-19
Method of Modulating the Activity of Functional Immune Molecules
App 20070166305 - Hanai; Nobuo ;   et al.
2007-07-19
Method of Modulating the Activity of Functional Immune Molecules
App 20070166300 - Hanai; Nobuo ;   et al.
2007-07-19
Anti-fibroblast growth factor-8 monoclonal antibody
Grant 7,241,568 - Hanai , et al. July 10, 2
2007-07-10
Method of treating atopic dermatitis using antibody against human interleukin-5 receptor alpha chain
Grant 7,238,354 - Koike , et al. July 3, 2
2007-07-03
Method of modulating the activity of functional immune molecules
Grant 7,214,775 - Hanai , et al. May 8, 2
2007-05-08
Process for producing humanized chimera antibody
App 20070073043 - Shitara; Kenya ;   et al.
2007-03-29
Method of treating allergy using antibody against human interleukin-5 receptor alpha chain
App 20070048304 - Koike; Masamichi ;   et al.
2007-03-01
Method of treatment by administering an antibody to human interleukin-5 receptor .alpha. chain
Grant 7,179,464 - Koike , et al. February 20, 2
2007-02-20
.alpha.,2,8-sialyltransferase
Grant 7,163,791 - Sasaki , et al. January 16, 2
2007-01-16
Antibody Composition-Producing Cell
App 20070010009 - Kanda; Yutaka ;   et al.
2007-01-11
Alpha-1,3-fucosyltransferase
App 20060246468 - Sasaki; Katsutoshi ;   et al.
2006-11-02
.alpha.-1,3-fucosyltransferase
Grant 7,094,530 - Sasaki , et al. August 22, 2
2006-08-22
Anti-human VEGF receptor FLT-1 monoclonal antibody
Grant 7,052,693 - Shitara , et al. May 30, 2
2006-05-30
Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3
Grant 7,045,129 - Shitara , et al. May 16, 2
2006-05-16
Antibody composition-producing cell
App 20060078990 - Kanda; Yutaka ;   et al.
2006-04-13
Antibody composition-producing cell
App 20060078991 - Kanda; Yutaka ;   et al.
2006-04-13
Antibody composition-producing cell
App 20060063254 - Kanda; Yutaka ;   et al.
2006-03-23
Antibody composition-producing cell
App 20060064781 - Kanda; Yutaka ;   et al.
2006-03-23
Process for producing humanized chimera antibody
App 20060057139 - Shitara; Kenya ;   et al.
2006-03-16
Process for producing humanized chimera antibody
App 20060058512 - Shitara; Kenya ;   et al.
2006-03-16
Anti-human VEGF receptor Flt-1 monoclonal antibody
App 20060034838 - Shitara; Kenya ;   et al.
2006-02-16
Method of modulating the activity of functional immune molecules
App 20060024800 - Hanai; Nobuo ;   et al.
2006-02-02
Recombinant antibody and antibody fragment
Grant 6,989,145 - Shitara , et al. January 24, 2
2006-01-24
Anti-human VEGF receptor Flt-1 monoclonal antibody
Grant 6,986,890 - Shitara , et al. January 17, 2
2006-01-17
Method of modulating the activity of functional immune molecules
App 20050276805 - Hanai, Nobuo ;   et al.
2005-12-15
Method of modulating the activity of functional immune molecules
App 20050272916 - Hanai, Nobuo ;   et al.
2005-12-08
Method of treating allergy using antibody against human interleukin-5 receptor alpha chain
App 20050272918 - Koike, Masamichi ;   et al.
2005-12-08
Antibody composition-producing cell
App 20050262593 - Kanda, Yutaka ;   et al.
2005-11-24
Process for producing humanized chimera antibody
Grant 6,965,024 - Shitara , et al. November 15, 2
2005-11-15
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
Grant 6,946,292 - Kanda , et al. September 20, 2
2005-09-20
Method for treating Th2-mediated disease
App 20050187380 - Shitara, Kenya ;   et al.
2005-08-25
Humanized antibodies
Grant 6,872,392 - Nakamura , et al. March 29, 2
2005-03-29
Monoclonal antibody for human telomerase catalytic subunit
App 20040219667 - Hanai, Nobuo ;   et al.
2004-11-04
Eosinophil-specific apoptosis inducer
App 20040136996 - Hosaka, Emi ;   et al.
2004-07-15
Anti-fibroblast growth factor-8 monoclonal antibody
App 20040091480 - Hanai, Nobuo ;   et al.
2004-05-13
Alpha,2,8-sialyltransferase
App 20040002138 - Sasaki, Katsutoshi ;   et al.
2004-01-01
Monoclonal antibody against human telomerase catalytic subunit
Grant 6,639,057 - Hanai , et al. October 28, 2
2003-10-28
Toxin conjugates
Grant 6,638,509 - Suzawa , et al. October 28, 2
2003-10-28
Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies
App 20030170758 - Hanai, Nobuo ;   et al.
2003-09-11
Anti-human VEGF receptor Flt-1 monoclonal antibody
Grant 6,617,160 - Shitara , et al. September 9, 2
2003-09-09
.alpha.,2,8-sialyltransferase
Grant 6,596,523 - Sasaki , et al. July 22, 2
2003-07-22
Antibody composition-producing cell
App 20030115614 - Kanda, Yutaka ;   et al.
2003-06-19
Antibody against human interleukin-5 receptor alpha chain
App 20030096977 - Koike, Masamichi ;   et al.
2003-05-22
Process for producing humanized chimera antibody
App 20030095964 - Shitara, Kenya ;   et al.
2003-05-22
Anti-human VEGF receptor Flt-1 monoclonal antibody
App 20030088075 - Shitara, Kenya ;   et al.
2003-05-08
Humanized antibodies
App 20030077276 - Nakamura, Kazuyasu ;   et al.
2003-04-24
Human chimeric antibody specific for the ganglioside GD3
Grant 6,437,098 - Shitara , et al. August 20, 2
2002-08-20
Anti-fibroblast growth factor-8 monoclonal antibody
App 20020099181 - Hanai, Nobuo ;   et al.
2002-07-25
Gene recombinant antibody and antibody fragment thereof
App 20020098527 - Shitara, Kenya ;   et al.
2002-07-25
Process for producing humanized chimera antibody
App 20020026036 - Shitara, Kenya ;   et al.
2002-02-28
Monoclonal antibody to human Mx protein MxA
Grant 6,180,102 - Hanai , et al. January 30, 2
2001-01-30
Toxin conjugates
Grant 6,103,236 - Suzawa , et al. August 15, 2
2000-08-15
Antibody against human interleukin-5-receptor .alpha. chain
Grant 6,018,032 - Koike , et al. January 25, 2
2000-01-25
Humanized antibodies to ganglioside GM.sub.2
Grant 5,939,532 - Nakamura , et al. August 17, 1
1999-08-17
DNA encoding humanized antibodies specific for the ganglioside GM.sub.2
Grant 5,874,255 - Nakamura , et al. February 23, 1
1999-02-23
Process for producing humanized chimera antibody
Grant 5,866,692 - Shitara , et al. February 2, 1
1999-02-02
Method of treating cancer using a chimera antibody
Grant 5,807,548 - Shitara , et al. September 15, 1
1998-09-15
Process for producing humanized chimera antibody
Grant 5,750,078 - Shitara , et al. May 12, 1
1998-05-12
.alpha.-3 sialyltransferase
Grant 5,494,790 - Sasaki , et al. February 27, 1
1996-02-27
Anti-DCC gene product specific monoclonal antibody
Grant 5,445,938 - Hanai , et al. August 29, 1
1995-08-29
.alpha.2.fwdarw.3 sialyltransferase
Grant 5,384,249 - Sasaki , et al. January 24, 1
1995-01-24
Process for preparing hybridoma cells which produce tumor-specific monoclonal antibodies
Grant 4,892,934 - Yoshida , et al. January 9, 1
1990-01-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed